Familial hypercholesterolaemia

The number of people in the denominator receiving DNA testing as part of a specialist assessment. Denominator – The number of people with a clinical diagnosis of FH. Data source: Local data collection using a dedicated database. b) Proportion of people with a clinical diagnosis of FH receiving DNA testing as part of a specialist assessment who give informed consent for the test. Numerator – The number of people in the denominator who give informed consent for the test. Denominator – The number of people with a clinical diagnosis of FH receiving DNA testing as part of a specialist assessment. Data source: Local data collection using a dedicated database. Outcome Patient satisfaction with process of informed consent. Data source: Local data collection. What the quality statement means for different audiences Service providers ensure that systems are in place for people with a clinical diagnosis of FH to be offered DNA testing as part of a specialist assessment. Specialists with expertise in FH offer DNA testing to people with a clinical diagnosis of FH as part of a specialist assessment. Commissioners ensure that they commission services that offer DNA testing to people with a clinical diagnosis of FH as part of
